MX2007016533A - Inhibidores de tirosina cinasa. - Google Patents

Inhibidores de tirosina cinasa.

Info

Publication number
MX2007016533A
MX2007016533A MX2007016533A MX2007016533A MX2007016533A MX 2007016533 A MX2007016533 A MX 2007016533A MX 2007016533 A MX2007016533 A MX 2007016533A MX 2007016533 A MX2007016533 A MX 2007016533A MX 2007016533 A MX2007016533 A MX 2007016533A
Authority
MX
Mexico
Prior art keywords
benzo
pyridin
methyl
pyrazol
cyclohepy
Prior art date
Application number
MX2007016533A
Other languages
English (en)
Spanish (es)
Inventor
Jonathan R Young
Christopher J Dinsmore
James P Jewell
Jason D Katz
Michelle R Machacek
Ryan D Otte
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX2007016533A publication Critical patent/MX2007016533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2007016533A 2005-06-23 2006-06-22 Inhibidores de tirosina cinasa. MX2007016533A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69322905P 2005-06-23 2005-06-23
US72906105P 2005-10-21 2005-10-21
US78947306P 2006-04-05 2006-04-05
PCT/US2006/024256 WO2007002258A2 (fr) 2005-06-23 2006-06-22 Inhibiteurs de tyrosine kinase

Publications (1)

Publication Number Publication Date
MX2007016533A true MX2007016533A (es) 2008-03-06

Family

ID=37595817

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007016533A MX2007016533A (es) 2005-06-23 2006-06-22 Inhibidores de tirosina cinasa.

Country Status (21)

Country Link
EP (1) EP1896422B1 (fr)
KR (1) KR20080018907A (fr)
AR (1) AR057377A1 (fr)
AT (1) ATE520664T1 (fr)
BR (1) BRPI0612518A2 (fr)
CR (1) CR9579A (fr)
CY (1) CY1112038T1 (fr)
DO (1) DOP2006000143A (fr)
EC (1) ECSP078017A (fr)
IL (1) IL187895A0 (fr)
MA (1) MA29643B1 (fr)
MX (1) MX2007016533A (fr)
NI (1) NI200700318A (fr)
NO (1) NO20080417L (fr)
NZ (1) NZ563711A (fr)
PE (1) PE20070167A1 (fr)
PL (1) PL1896422T3 (fr)
PT (1) PT1896422E (fr)
SI (1) SI1896422T1 (fr)
TW (1) TW200738638A (fr)
WO (1) WO2007002258A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
US7893081B2 (en) * 2007-12-20 2011-02-22 Merck & Co., Inc. Tyrosine kinase inhibitors
EP2482821A4 (fr) 2009-09-30 2013-03-06 Merck Sharp & Dohme Sels de chlorhydrate cristallins d'inhibiteurs de kinase c-met
CA2772127A1 (fr) 2009-09-30 2011-04-07 Merck Sharp & Dohme Ltd Formulations pour des inhibiteurs de la kinase c-met
US20130315895A1 (en) 2010-07-01 2013-11-28 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
JP6864953B2 (ja) 2014-12-09 2021-04-28 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Ａｘｌに対するヒトモノクローナル抗体
WO2016135041A1 (fr) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Protéines de fusion et anticorps les contenant pour favoriser l'apoptose
US20220143049A1 (en) 2019-03-21 2022-05-12 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
EP4054579A1 (fr) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Méthodes pour le traitement de cancers qui ont acquis une résistance aux inhibiteurs de kinase
WO2021148581A1 (fr) 2020-01-22 2021-07-29 Onxeo Nouvelle molécule dbait et son utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE363473T1 (de) * 2001-09-19 2007-06-15 Pharmacia Corp Substituierte pyrazoloverbindungen zur behandlung von entzündungen
AU2003230758A1 (en) * 2002-04-02 2003-10-20 Merck And Co., Inc. 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists

Also Published As

Publication number Publication date
NO20080417L (no) 2008-03-18
TW200738638A (en) 2007-10-16
WO2007002258A2 (fr) 2007-01-04
CY1112038T1 (el) 2015-11-04
KR20080018907A (ko) 2008-02-28
PT1896422E (pt) 2011-11-08
PE20070167A1 (es) 2007-04-16
ATE520664T1 (de) 2011-09-15
CR9579A (es) 2008-03-06
MA29643B1 (fr) 2008-07-01
IL187895A0 (en) 2008-03-20
DOP2006000143A (es) 2007-02-28
SI1896422T1 (sl) 2011-11-30
AR057377A1 (es) 2007-11-28
EP1896422B1 (fr) 2011-08-17
PL1896422T3 (pl) 2012-01-31
EP1896422A2 (fr) 2008-03-12
WO2007002258A3 (fr) 2007-06-07
BRPI0612518A2 (pt) 2010-11-23
ECSP078017A (es) 2008-01-23
NZ563711A (en) 2010-12-24
NI200700318A (es) 2008-05-23

Similar Documents

Publication Publication Date Title
RU2408584C2 (ru) Ингибиторы тирозинкиназы
CN108602776B (zh) 用作irak抑制剂的杂芳基化合物及其用途
CA2656578C (fr) Inhibiteurs de la tyrosine kinase
EP3268004B1 (fr) Inhibiteurs de l'activité d'irak4 à base de pyrrolopyridazine
EP3200787B1 (fr) Inhibiteurs de l'activité de irak 4
WO2016144849A1 (fr) Thénopyrazines utilisées comme inhibiteurs de l'activité de l'irak4
AU2010285621A1 (en) Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
EP2593107A1 (fr) Inhibiteurs de la tyrosine kinase
KR20200083529A (ko) 파르네소이드 x 수용체 조정제로서의 알켄 스피로시클릭 화합물
MX2007016533A (es) Inhibidores de tirosina cinasa.
AU2009322656A1 (en) Inhibitors of phosphoinositide dependent kinase 1 (PDK1)
US7893081B2 (en) Tyrosine kinase inhibitors
ES2370419T3 (es) Inhibidores de tirosina quinasa.
AU2011296312A1 (en) Tyrosine kinase inhibitors

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: ABBVIE INC.